妊娠期急性脂肪肝围产期不良结局与术中输血关联的探索性分析及风险预测模型构建

邓桂花 ,  黄璜 ,  汪萍萍 ,  龙馨妍 ,  周慧星 ,  孙亚纯 ,  徐筠娉

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (6) : 734 -742.

PDF (1895KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (6) : 734 -742. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.06.005
论著

妊娠期急性脂肪肝围产期不良结局与术中输血关联的探索性分析及风险预测模型构建

作者信息 +

Association between the perinatal adverse outcomes in acute fatty liver of pregnancy and intraoperative blood transfusion and its prediction model

Author information +
文章历史 +
PDF (1940K)

摘要

目的 分析妊娠期急性脂肪肝(AFLP)患者术中输血与围产期不良结局(定义为孕产妇死亡、肝性脑病等复合终点)的关联;探讨 AFLP 围产期不良结局独立危险因素,构建并验证早期风险预测模型。方法 回顾性纳入 2008 年 1 月至 2025 年 1 月本院收治的 56 例 AFLP 患者。 采用 χ2 检验比较输血组与未输血组的不良结局发生率;通过单因素及多因素 Firth 惩罚 Logistic 回归筛选独立预测因子。 引入中介效应分析术中输血对围产期不良结局的潜在路径。 基于筛选变量建立联合预测模型,使用 Bootstrap 法(1 000 次重抽样)进行内部验证,以受试者工作特征(ROC)曲线评估区分度,通过校准曲线评估一致性。 最后将模型可视化为列线图。结果 57. 1%(32/ 56)的患者在终止妊娠期间接受了血制品输注。 多因素 Firth 惩罚 Logistic 回归分析显示,在本研究样本量下未检测到术中输血对围产期不良结局的独立统计学效应(OR= 0. 812,95%CI:0. 133-3. 698,P= 0. 797);中介效应分析亦未发现显著的间接效应。 AFLP 围产期不良结局独立危险因素包括:术前纤维蛋白原降低(OR= 14. 062,95%CI:2. 389-126. 656,P = 0. 003)、妊娠合并感染(OR = 4. 536,95%CI:1. 143-22. 107,P = 0. 031) 和剖宫产(OR = 8. 691,95% CI:1. 321-90. 081,P= 0. 023)。 联合预测模型受试者工作特征(ROC)曲线下面积(AUC) 为 0. 881(95%CI:0. 793-0. 969,P< 0. 001),在最佳截断值下,模型的灵敏度为 65. 6%,特异度为 95. 8%,阳性预测值为 95. 5%,阴性预测值为 67. 6%。 Bootstrap 法内部验证显示预测模型区分度良好且未明显过拟合。 校准曲线提示,模型预测风险与实际观测风险具有一致性。 基于上述结果,本研究构建了 AFLP 围产期不良结局的列线图模型。结论 在本研究有限样本量下,未能检出术中输血对 AFLP 患者围产期不良结局的独立效应。 由术前纤维蛋白原降低、妊娠合并感染及剖宫产构建的 Firth 惩罚 Logistic 回归模型区分度和校准能力良好,该列线图可为早期识别高危患者并实施主动干预提供探索性工具。

Abstract

Objective To analyze the association between intraoperative blood transfusion and adverse perinatal out-comes(a composite of maternal death, hepatic encephalopathy, etc) in patients with acute fatty liver of pregnancy (AFLP), identify independent risk factors for these outcomes, and develop and validate a risk prediction model for early i-dentification of high-risk patients. Methods Clinical data of 56 AFLP patients admitted to our hospital from January 2008 to January 2025 were retrospectively analyzed. The chi-square test was used to compare the incidence of adverse perinatal outcomes between the transfusion group and the non-transfusion group. Univariate and multivariate Firth-penalized logistic regression analyses were performed to identify independent predictors of adverse outcomes. Based on the identified inde-pendent risk factors, a combined prediction model was developed. Internal validation was performed using the Bootstrap method (1 000 resamplings) to assess the model′s generalizability. Model performance was evaluated using receiver operat-ing characteristic(ROC) curves and calibration curves. Finally, a nomogram for predicting adverse perinatal outcomes in AFLP was constructed. Results Overall, 57. 1%(32/ 56) of the patients received blood product transfusion during the ter-mination of pregnancy. Multivariate Firth-penalized logistic regression analysis showed that, given the limited sample size, intraoperative blood transfusion had no independent statistical effect on adverse outcomes (OR = 0. 812, 95%CI:0. 133-3. 698, P= 0. 797). Mediation analysis also revealed no significant indirect effect. The independent risk factors were de-creased preoperative fibrinogen (OR= 14. 062, 95%CI:2. 389-126. 656, P = 0. 003), pregnancy with infection (OR = 4. 536, 95%CI:1. 143-22. 107, P= 0. 031), and cesarean section (OR = 8. 691, 95%CI:1. 321-90. 081, P = 0. 023). The combined prediction model achieved an AUC of 0. 881 (95% CI:0. 793-0. 969, P<0. 001), indicating good discrimi-nation. At the optimal cut-off value, the sensitivity was 65. 6%, specificity 95. 8%, positive predictive value 95. 5%, and negative predictive value 67. 6%. Internal validation by the Bootstrap method showed that the predictive model had good dis-crimination and no obvious overfitting. The calibration curve demonstrated that the model′s predicted risk was consistent with the actual observed risk. Based on this, an AFLP perinatal adverse outcome nomogram model was constructed. Con-clusion Under the limited sample size of this study, no independent statistical effect of intraoperative blood product infu-sion on adverse perinatal outcomes in AFLP patients was detected. A multivariate Firth-penalized logistic regression model incorporating decreased preoperative fibrinogen, pregnancy with infection, and cesarean delivery demonstrated good discrimi-nation and calibration. The derived nomogram may serve as an exploratory tool for early risk stratification and proactive inter-vention.

关键词

妊娠期急性脂肪肝 / 术中输血 / 妊娠合并感染 / 纤维蛋白原 / 不良结局 / 预测模型

Key words

acute fatty liver of pregnancy / intraoperative blood transfusion / infection complicating pregnancy / fibrino-gen / perinatal outcome / prediction model

引用本文

引用格式 ▾
邓桂花,黄璜,汪萍萍,龙馨妍,周慧星,孙亚纯,徐筠娉. 妊娠期急性脂肪肝围产期不良结局与术中输血关联的探索性分析及风险预测模型构建[J]. 中国输血杂志, 2026, 39(6): 734-742 DOI:10.13303/j.cjbt.issn.1004-549x.2026.06.005

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

MORRISON M A, CHUNG Y, HENEGHAN M A. Man-aging hepatic complications of pregnancy:practical strat-egies for clinicians[J].BMJ Open Gastroenterol, 2022, 9:e000624.

[2]

DWIVEDI S, RUNMEI M. Retrospective study of seven cases with acute Fatty liver of pregnancy[J].ISRN Ob-stet Gynecol, 2013, 2013:730569.

[3]

AHMED K T, ALMASHHRAWI A A, RAHMAN R N, et al. Liver diseases in pregnancy: diseases unique to pregnancy[J].World J Gastroenterol, 2013, 19(43): 7639-7646.

[4]

LISMAN T, BERNAL W. Hemostatic issues inpregnan-cy-related liver disease[J].Thromb Res, 2017, 151 (Suppl)1:S78-S81.

[5]

BIANCHINI M, DE PIETRI L, VILLA E. Coagulopathy in liver diseases:complication or therapy[J].Dig Dis, 2014, 32(5):609-614.

[6]

邓桂花, 龙馨妍, 周慧星, 等. 妊娠期急性脂肪肝临 床特征及减少血浆置换的预测因素分析-单中心 诊疗决策优化[J].中国计划生育和妇产科, 2025, 17(9):82-87.

[7]

DENG G H, LONG X Y, ZHOU H X, et al. Clinical features of acute fatty liver of pregnancy and predictors for reducing plasma exchange-a single-center decision optimization study[J].Chin J Fam Plann Gynecol, 2025, 17(9):82-87.

[8]

KNIGHT M, NELSON-PIERCY C, KURINCZUK J J, et al. A prospective national study of acute fatty liver of pregnancy in the UK[J].Gut, 2008, 57(7):951-956.

[9]

中华医学会妇产科学分会产科学组. 妊娠期急性脂 肪肝临床管理指南(2022)[J].临床肝胆病杂志, 2022, 38(4):776-783.

[10]

Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association.Clinical man-agement guidelines for acute fatty liver of pregnancy in China (2022)[J].Chin J Clin Hepatol, 2022, 38(4): 776-783.

[11]

FORKIN K T, COLQUHOUN D A, NEMERGUT E C, et al. The coagulation profile of end-stage liver disease and considerations for intraoperative management[J].Anesth Analg, 2018, 126(1):46-61.

[12]

ROBERTS L N, BERNAL W. Management of bleeding and thrombosis in critically ill patients with liver disease[J].Semin Thromb Hemost, 2015, 41(5):520-526.

[13]

MONCHARMONT P, BARDAY G, MEYER F, et al. Adverse transfusion reactions in patients with liver dis-ease[J].Transfus Med, 2018, 28(4):331-332.

[14]

LISMAN T, PORTE R J. Value of preoperative hemosta-sis testing in patients with liver disease for perioperative hemostatic management[J].Anesthesiology, 2017, 126 (2):338-344.

[15]

TERRAULT N A, WILLIAMSON C . Pregnancy-associat-ed liver diseases[J].Gastroenterology, 2022, 163(1): 97-117.

[16]

MASSICOTTE L, SASSINE M P, LENIS S, et al. Sur-vival rate changes with transfusion of blood products dur-ing liver transplantation[J].Can J Anaesth, 2005, 52 (2):148-155.

[17]

VAMVAKAS E C, BLAJCHMAN M A. Transfusion-re-lated mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their preven-tion[J].Blood, 2009, 113(15):3406-3417.

[18]

BENSON A B, BURTON J R, AUSTIN G L, et al. Dif-ferential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation[J].Liver Transpl 2011, 17(2):149-158.

[19]

NELSON D B, BYRNE J J, CUNNINGHAM F G. Acute fatty liver of pregnancy[J].Obstet Gynecol, 2021, 137 (3):535-546.

[20]

PAN X, CHU R, QIAO X, et al. Association of adverse perinatal outcomes with blood components transfusion in patients with acute fatty liver of pregnancy[J].Int J Womens Health, 2025, 17:21-32.

[21]

LISMAN T, BAKHTIARI K, ADELMEIJER J, et al. Intact thrombin generation and decreased fibrinolytic ca-pacity in patients with acute liver injury or acute liver fail-ure[J].J Thromb Haemost, 2012, 10(7):1312-1319.

[22]

邓桂花, 孙亚纯, 王雷萍, 等. 妊娠期急性脂肪肝患 者住院时间影响因素分析及预测模型建立[J].中国 输血杂志, 2024, 37(4):431-438.

[23]

DENG G H, SUN Y C, WANG L P. Analysis on factors influencing the length of hospital stay of the AFLP pa-tients and the establishment of prediction model[J].Chin J Blood Transfusion, 2024, 37(4):431-438.

[24]

付丽华, 曹彦君, 王晓娟, 等. 影响妊娠急性脂肪肝 患者治愈时间的危险因素[J]. 中国肝脏病杂志(电子 版),2021, 13(2):52-57.

[25]

FU L H, CAO Y J, WANG X J. Risk factors of the cure time of patients with acute fatty liver of pregnancy[J].Chin J Liver Dis(Electron Ed), 2021, 13(2):52-57.

基金资助

中华预防医学会血液安全科研资金支持课题(YFYXH-2026-XYAQ-25)

AI Summary AI Mindmap
PDF (1895KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉